The purpose of this study was to examine factors important to older adults who agreed with a deprescribing recommendation given by a general practitioner (GP) to a hypothetical patient experiencing polypharmacy. We conducted an online, vignette-based, experimental study in the United Kingdom, United States and Australia with participants ≥65 years. The primary outcome was an agreement with a deprescribing recommendation (6-point Likert scale; 1 = strongly disagree and 6 = strongly agree). We performed a content analysis of the free-text reasons provided by participants who agreed with deprescribing (score of 5 or 6). Among 2656 participants who agreed with deprescribing, approximately 53.7% shared a preference for following the GP's recommendation or considered the GP the expert. The medication was referred to as a reason for deprescribing by 35.6% of participants. Less common themes included personal experience with medicine (4.3%) and older age (4.0%). Older adults who agreed with deprescribing in a hypothetical vignette most frequently reported a desire to follow the recommendations given the GP's expertise. Future research should be conducted to help clinicians efficiently identify patients who have a strong desire to follow the doctor's recommendations related to deprescribing, as this may allow for a tailored, brief deprescribing conversation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/bcpt.13857 | DOI Listing |
Patient Prefer Adherence
December 2024
Center for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
Purpose: Multimorbidity and polypharmacy have emerged as significant global issues, heightening the risks of potentially inappropriate medications (PIMs). This necessitates medication optimization through deprescribing. Understanding patients' decision-making preferences regarding medication cessation is crucial for mitigating medication-related risks.
View Article and Find Full Text PDFAge Ageing
November 2024
Faculty of Pharmaceutical Sciences, The University of British Columbia-Vancouver Campus, Vancouver, British Columbia V6T 1Z4, Canada.
J Am Med Dir Assoc
January 2025
Department of Family Medicine and Population Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Larry A. Green Center, Richmond, VA, USA.
Objectives: Survey nursing home (NH) clinicians about the indications for NH gabapentinoid use, the factors driving increased prescribing, and their experiences with gabapentinoid deprescribing.
Design: Online clinician survey.
Setting And Participants: NH clinicians prescribing gabapentinoids in US NHs.
J Pain Symptom Manage
November 2024
Department of Medical Oncology (E.E.C.M.E., I.E.P., E.C.T.G., C.C.D.V.D.R.), Erasmus Medical Center, Cancer Institute Rotterdam, Netherlands.
Context: Medications may become inappropriate for patients in the last phase of life and may even compromise their quality of life.
Objective: To find consensus on recommendations regarding deprescribing of medications for adult patients with a life expectancy of six months or less.
Methods: Experts working in palliative care or other relevant disciplines were asked to participate in this international Delphi study.
Can Pharm J (Ott)
May 2024
Laval Université, Québec; and the School of Pharmacy, Memorial University of Newfoundland, Newfoundland and Labrador.
Background: Sustainable implementation of new professional services into clinical practice can be difficult. In 2019, a population-wide initiative called SaferMedsNL was implemented across the province of Newfoundland and Labrador (NL), to promote appropriate medication use. Two evidence-based interventions were adapted to the context of NL to promote deprescribing of proton pump inhibitors and sedatives.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!